Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-27

Clinical Trial Update: Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab

View source ↗

Summary

A completed trial examines whether acne rash during adolescence predicts skin reactions to cetuximab in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERBITUX (cetuximab)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Colorectal Cancer Metastatic | Status: COMPLETED